Six cycles of Doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: cancer and leukemia group B 40101
- Citation:
- J Clin Oncol vol 30 (33) 4071-4076
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 1
- Parents:
- 340
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- L. N. Shulman C. T. Cirrincione D. A. Berry H. P. Becker E. A. Perez R. O'Regan S. Martino J. N. Atkins E. Mayer C. J. Schneider G. Kimmick L. Norton H. Muss E. P. Winer C. Hudis
- Networks:
- Study
- CALGB-40101
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: